Product Information
AMITRIPTYLINE HCL 50 MG TAB is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.0957 per EA under NDC 70710122700. Its NADAC has been published 396 times since Nov 28, 2018.
Strength
50 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710122700
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AMITRIPTYLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA210086On Market Since
12/26/2017
Pharmacological Classes
Price Statistics
The NADAC for AMITRIPTYLINE HCL 50 MG TAB has been published 396 times since Nov 28, 2018, and over the history we have for it it has declined 69.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0957 per EA |
|---|---|
| All-time high | $0.3162 (Dec 12, 2018) |
| All-time low | $0.0677 (Nov 20, 2024) |
| 52-week high | $0.1019 |
| 52-week low | $0.0889 |
| Median price | $0.1048 |
| Average price | $0.1574 |
| Largest weekly change | +40.1% (Aug 21, 2024) |
| Weeks tracked | 396 |
| Tracking since | Nov 28, 2018 |
Generic Alternatives
The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of AMITRIPTYLINE HCL 50 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for AMITRIPTYLINE HCL 50 MG TAB, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.0957 per EA (NDC 70710122700), effective Jun 24, 2026.
How has the price of AMITRIPTYLINE HCL 50 MG TAB changed over time?
Over the history we have for it, the NADAC for AMITRIPTYLINE HCL 50 MG TAB has declined 69.7%. It has been tracked across 396 weekly CMS publications since Nov 28, 2018.
What are the highest and lowest recorded NADAC prices for AMITRIPTYLINE HCL 50 MG TAB?
Since Nov 28, 2018, the NADAC for AMITRIPTYLINE HCL 50 MG TAB has ranged from a low of $0.0677 (Nov 20, 2024) to a high of $0.3162 (Dec 12, 2018), with a median of $0.1048 per EA.
Are there cheaper alternatives to AMITRIPTYLINE HCL 50 MG TAB?
12 NADAC-published products share the same active ingredient, strength, and dosage form as AMITRIPTYLINE HCL 50 MG TAB, but none are currently priced below it.
Who manufactures AMITRIPTYLINE HCL 50 MG TAB?
AMITRIPTYLINE HCL 50 MG TAB (NDC 70710122700) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification